COVID Research Articles

New research shows early intervention could slow the progression of COVID-19.

Patients with severe cases of COVID-19 were treated with Remdesivir for 5 and 10 days to determine efficacy of the duration of treatment.

Article featuring multiple Providence doctors published in the Journal for ImmunoTherapy of Cancer focused on immunological manipulations to lessen the severity of COVID-19.

How the clinical support team at Providence met an unprecedented challenge.

This report covers the first case of 2019-nCoV infection confirmed in the United States and describes the identification, diagnosis, clinical course, and management of the case.

The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

This document identifies the potential risks of exposure to patients, allied health care staff, industry representatives and hospital administrators.

Gastrointestinal manifestations of COVID-19 are immediately reminiscent of previous coronavirus outbreaks and should raise concern about faecal shedding as a mode of transmission.

Described in this case series are the first 12 US patients confirmed to have COVID-19 from January 20 to February 5, 2020.

This study in the New England Journal of medicine examines clinical data from 24 COVID positive patients.

In an interview with the New England Journal of Medicine, Dr. George Diaz, chief of infectious diseases at Providence Regional Medical Center Everett, explains how Providence responded to the first U.